Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • M&A / Deals
  • Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion
  • M&A / Deals

Amneal Agrees to Acquire Kashiv BioSciences for Total Payment up to $1.1 Billion

Big Molecule Watch

On April 22, 2026 Amneal Pharmaceuticals, Inc.

Read full story

pharminent May 4, 2026 (Last updated: May 5, 2026)

Big Molecule Watch

On April 22, 2026 Amneal Pharmaceuticals, Inc.

Read full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Part D Mail Order Prescription Drugs
Next: Cytospire hauls in $83M for a new type of T cell engager

Related Stories

  • M&A / Deals

Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar

pharminent July 10, 2026
  • M&A / Deals

GSK ends dementia alliance with Alector after setbacks

pharminent July 9, 2026
  • M&A / Deals

AstraZeneca, GSK intensify China ties with Sino Biopharm deals

pharminent July 8, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.